SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-005175
Filing Date
2020-01-17
Accepted
2020-01-17 17:08:20
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm203595d1_s3.htm S-3 229363
2 EXHIBIT 5.1 tm203595d1_ex5-1.htm EX-5.1 17964
3 EXHIBIT 23.1 tm203595d1_ex23-1.htm EX-23.1 3359
4 GRAPHIC tm203595d1_s3img001.jpg GRAPHIC 3325
5 GRAPHIC tm203595d1_s3img002.jpg GRAPHIC 5296
6 GRAPHIC image_001.gif GRAPHIC 1937
7 GRAPHIC image_002.jpg GRAPHIC 7040
  Complete submission text file 0001104659-20-005175.txt   276442
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235970 | Film No.: 20534303
SIC: 2836 Biological Products, (No Diagnostic Substances)